Efficacy and safety of prolonged release budesonide granules in mesalazine-refractory ulcerative colitis: A multi-centre Phase IIa study (TOPICAL-1)

BACKGROUND: In patients with mesalazine-refractory ulcerative colitis, systemic corticosteroids are the treatment of choice. OBJECTIVE: To evaluate the efficacy and safety of prolonged release budesonide granules for the induction of remission in patients with mesalazine-refractory ulcerative coliti...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:United European Gastroenterol J
Hlavní autoři: Fellermann, Klaus, Schiefke, Ingolf, Rácz, István, Derova, Jelena, Jonaitis, Laimas, Wehrum, Sarah, Nacak, Tanju, Greinwald, Roland
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2020
Témata:
Inflammatory Bowel Disease
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724525/
https://ncbi.nlm.nih.gov/pubmed/33028169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620962632
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky